A Blueprint for Supply Chain Success
A policy framework aims to boost the manufacture of critical drugs in the USA
Maryam Mahdi | | Quick Read
The Association of Accessible Medicines (AAM) has released the report ‘A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain’ that offers advice on how the Federal Government could create capacity to manufacture critical medicines in the USA and allied countries (1).
Suggestions include the government’s direct engagement with pharma companies to identify opportunities for investment; the FDA’s improved engagement with manufacturers, as well as the agency developing more efficient regulatory processes for the review and approval of pharmaceutical products; and the scale-up of the US Department of Health and Human Services to expand the nation’s supply chain.
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.
- AAM, “A Blueprint for Enhancing the Security of the US Pharmaceutical Supply Chain”, (2020). Available at: https://bit.ly/3d5Rj1t